Larvol Delta - WPD-Pharmaceuticals-Plans-to-Commence-Phase-IbII-Study-of-Berubicin-for-the-Treatment-of-Glioblastoma-in-2H-2021

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.globenewswire.com/news-release/2021/06/28/2253787/0/en/WPD-Pharmaceuticals-Plans-to-Commence-Phase-Ib-II-Study-of-Berubicin-for-the-Treatment-of-Glioblastoma-in-2H-2021.html

Jun 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next